172 related articles for article (PubMed ID: 23007103)
21. Cell viability of four corneoconjunctival cell lines exposed to five preservatives and a surfactant used for infection control in eyedrops.
Ayaki M; Iwasawa A
Biocontrol Sci; 2011 Sep; 16(3):117-21. PubMed ID: 21946322
[TBL] [Abstract][Full Text] [Related]
22. Comparison of corneal safety and intraocular pressure-lowering effect of tafluprost ophthalmic solution with other prostaglandin ophthalmic solutions.
Kumagami T; Wakiyama H; Kusano M; Kajiyama A; Miura Y; Uematsu M; Yoneda A; Kurihara J; Suzuma K; Kitaoka T
J Ocul Pharmacol Ther; 2014 May; 30(4):340-5. PubMed ID: 24576066
[TBL] [Abstract][Full Text] [Related]
23. Conjunctiva-associated lymphoid tissue (CALT) reactions to antiglaucoma prostaglandins with or without BAK-preservative in rabbit acute toxicity study.
Liang H; Baudouin C; Labbe A; Riancho L; Brignole-Baudouin F
PLoS One; 2012; 7(3):e33913. PubMed ID: 22442734
[TBL] [Abstract][Full Text] [Related]
24. A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry.
Kahook MY; Fechtner RD; Katz LJ; Noecker RJ; Ammar DA
Curr Eye Res; 2012 Feb; 37(2):101-8. PubMed ID: 22040280
[TBL] [Abstract][Full Text] [Related]
25. Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.
Wu JH; Wang TH; Huang JY; Su CC
J Ocul Pharmacol Ther; 2021 Dec; 37(10):556-564. PubMed ID: 34610257
[No Abstract] [Full Text] [Related]
26. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4594-9. PubMed ID: 16303954
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system.
Yee RW; Norcom EG; Zhao XC
Adv Ther; 2006; 23(4):511-9. PubMed ID: 17050493
[TBL] [Abstract][Full Text] [Related]
28. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.
Liang H; Baudouin C; Pauly A; Brignole-Baudouin F
Br J Ophthalmol; 2008 Sep; 92(9):1275-82. PubMed ID: 18723745
[TBL] [Abstract][Full Text] [Related]
29. [Benzalkonium chloride daily dose--an important criterion in glaucoma treatment].
Výborný P; Sicáková S
Cesk Slov Oftalmol; 2011 Apr; 67(2):63-6. PubMed ID: 21751744
[TBL] [Abstract][Full Text] [Related]
30. [Preservative substances - the daily dose of benzalkonium chloride in glaucoma treatment from the patients point of view].
Výborný P; Sičáková S; Veselá Flórová Z
Cesk Slov Oftalmol; 2014 Jun; 70(3):95-7. PubMed ID: 25032794
[TBL] [Abstract][Full Text] [Related]
31. Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines.
Ammar DA; Kahook MY
Br J Ophthalmol; 2011 Oct; 95(10):1466-9. PubMed ID: 21602479
[TBL] [Abstract][Full Text] [Related]
32. Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma.
Bouchemi M; Roubeix C; Kessal K; Riancho L; Raveu AL; Soualmia H; Baudouin C; Brignole-Baudouin F
Toxicol In Vitro; 2017 Jun; 41():21-29. PubMed ID: 28214551
[TBL] [Abstract][Full Text] [Related]
33. [Toxicity of preserved and unpreserved beta-blocker eyedrops in an in vitro model of human conjunctival cells].
de Saint Jean M; Debbasch C; Brignole F; Rat P; Warnet JM; Baudouin C
J Fr Ophtalmol; 2000 Feb; 23(2):111-21. PubMed ID: 10705112
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo corneal effects of latanoprost combined with brimonidine, timolol, dorzolamide, or brinzolamide.
Fukuda M; Takeda N; Shibata S; Shibata N; Shibata T; Sugiyama K; Sasaki H
Eur J Pharmacol; 2016 Sep; 787():43-6. PubMed ID: 27181069
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost.
Chang C; Zhang AQ; Kagan DB; Liu H; Hutnik CM
Clin Exp Ophthalmol; 2015 Mar; 43(2):164-72. PubMed ID: 25041649
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines.
Ayaki M; Iwasawa A
Clin Ophthalmol; 2010 Aug; 4():919-24. PubMed ID: 20823934
[TBL] [Abstract][Full Text] [Related]
37. Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets.
Nakagawa S; Usui T; Yokoo S; Omichi S; Kimakura M; Mori Y; Miyata K; Aihara M; Amano S; Araie M
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5154-60. PubMed ID: 22695966
[TBL] [Abstract][Full Text] [Related]
38. The Effects of Antiglaucoma Ophthalmic Solutions on the Cornea Revealed by a Corneal Electrical Resistance Device.
Takeda N; Fukuda M; Sasaki H; Sugiyama K
J Ocul Pharmacol Ther; 2021 Mar; 37(2):97-103. PubMed ID: 33439755
[No Abstract] [Full Text] [Related]
39. Effects of 20% Human Serum on Corneal Epithelial Toxicity Induced by Benzalkonium Chloride: In Vitro and Clinical Studies.
Moon J; Ko JH; Yoon CH; Kim MK; Oh JY
Cornea; 2018 May; 37(5):617-623. PubMed ID: 29300263
[TBL] [Abstract][Full Text] [Related]
40. Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells.
Ayaki M; Iwasawa A; Inoue Y
Clin Ophthalmol; 2010 Oct; 4():1217-22. PubMed ID: 21060675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
